EIR Ventures
  • This is Eir Ventures
  • Team
  • Investments
  • Sustainability
  • News
  • Contact
    • Investor Login
    • Download
Select Page
IO Biotech, Inc. Announces Pricing of Initial Public Offering

IO Biotech, Inc. Announces Pricing of Initial Public Offering

by Thomas Rønn | Nov 5, 2021 | Press Releases, Uncategorised

Congratulations to our portfolio company IO Biotech on the successful IPO on NASDAQ. Great achievement for this pioneering company, and a milestone in the development of new pioneering treatments for Cancer patients based on the company’s T-win technology. Read the...

Recent Posts

  • Eir Ventures invests in Henlez
  • Eir Ventures portfolio company, Pretzel Therapeutics, announces USD 72,5M series A financing
  • Eir Ventures invests in Hoba Therapeutics
  • Eir Ventures joins oversubscribed investment round in Attgeno
  • Eir Ventures strengthens team – appoints three new Partners

Recent Comments

    Get in Touch
    Eir Ventures is located in Stockholm, Sweden, and Copenhagen, Denmark.
    Sweden Office
    Grev Turegatan 27
    SE-114 38 Stockholm
    Sweden
    Denmark Office
    Havnegade 39
    DK-1058 Copenhagen
    Denmark
    Contact us
    info@eirventures.eu
    ©2021 Eir Ventures.